Chronic psychosis in Turner's Syndrome: a case report and a review
Article Abstract:
Turner's syndrome (TS) is characterized by the absence of the second sex chromosome, leaving 45 chromosomes with a single X. As a result, the gonads do not develop, no significant sex hormone is produced, and the sexual tissues retain a female resting state. Girls with TS lack adequate estrogen and do not develop secondary sex characteristics without hormone therapy. Impaired intelligence may occur, but emotional disturbance and psychosis are not characteristic of this disorder. In 2,946 studies of TS, only seven cases of psychosis were reported. It has been hypothesized that the absence of an X chromosome results in some immunity for major psychiatric disturbances. However, since TS is rare, and occurs in only 0.01 percent of newborn girls, this theory is difficult to confirm. The case report of a 59-year-old woman with TS who became chronically psychotic and demented is presented. After a fairly normal childhood, including good academic functioning, she developed epilepsy at age 15. Two years later she began having auditory hallucinations. She was admitted to a mental hospital when she was 28 after episodes of violent behavior. Neurological findings were normal and she was diagnosed with schizophrenia. Her symptoms were controlled with anti-seizure and antipsychotic drugs, and she did well for several years until her mental state began to deteriorate. The patient became osteoporotic and developed diabetes at age 51. By age 57 she was demented, unable to communicate and unable to control her urinary or bowel movements. She also developed bilateral deafness. Examination with computerized tomography demonstrated brain atrophy. It is suggested that when psychotic illness does occur in TS patients, it is the result of brain damage. (Consumer Summary produced by Reliance Medical Information, Inc.)
Publication Name: British Journal of Psychiatry
Subject: Health
ISSN: 0007-1250
Year: 1989
User Contributions:
Comment about this article or add new information about this topic:
The myth of elevated serum creatine phosphokinase level and neuroleptic malignant syndrome
Article Abstract:
Neuroleptic malignant syndrome (NMS) is a relatively rare but potentially fatal condition associated with the administration of neuroleptic (antipsychotic) medications. NMS symptoms include rigidity and tremors, high fevers, altered consciousness including coma, and chemical imbalances. It is posited that there is a trend to overdiagnose NMS and to label every neuroleptic overdose as NMS if a raised creatine phosphokinase (CPK) level is found. CPK is an enzyme which is a sensitive marker of muscle injury or stress. For example, CPK serum levels are routinely checked in various muscle disorders and during heart attacks. A limitation of CPK measurement is its lack of specificity, since during hospitalization patients often have elevated serum CPK levels due to intramuscular injections, use of restraints and other forms of stress. Elevated levels have also been reported in patients who have poor reactions to neuroleptics. Many other diseases or minor muscle insults can also lead to CPK leakage, causing serum levels to rise. Therefore, caution is suggested while considering a diagnosis of NMS in patients with elevated CPK serum levels but without fever or other clinical NMS symptoms, especially since NMS is a neuroleptic dose-dependent reaction, and other interpretations of elevated CPK are so non-specific. (Consumer Summary produced by Reliance Medical Information, Inc.)
Publication Name: British Journal of Psychiatry
Subject: Health
ISSN: 0007-1250
Year: 1991
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: A fertile woman with non-mosaic Turner's syndrome:a case report and review of the literature. The prevalence and patterns of care of Huntington's Chorea in Grampian
- Abstracts: Multimodal imaging in Alzheimer's disease: the relationship between MRI, SPECT, cognitive and pathological changes
- Abstracts: Symptomatic trans-sexualism. Further investigation of the predictors of outcome following first schizophrenic episodes